Strs Ohio Sells 29,246 Shares of Amdocs Limited $DOX

Strs Ohio lowered its stake in Amdocs Limited (NASDAQ:DOX) by 91.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 2,640 shares of the technology company’s stock after selling 29,246 shares during the period. Strs Ohio’s holdings in Amdocs were worth $217,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of DOX. Amundi grew its holdings in shares of Amdocs by 73.0% in the first quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after acquiring an additional 5,816 shares during the period. Millennium Management LLC grew its stake in shares of Amdocs by 458.3% during the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after purchasing an additional 55,038 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Amdocs by 12.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after purchasing an additional 37,087 shares during the period. Empowered Funds LLC lifted its stake in shares of Amdocs by 12.0% in the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after purchasing an additional 1,709 shares during the period. Finally, Jane Street Group LLC boosted its holdings in shares of Amdocs by 195.4% in the first quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after buying an additional 76,683 shares during the last quarter. 92.02% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on DOX shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Stifel Nicolaus cut their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Bank of America decreased their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Finally, Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, January 3rd. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.00.

Amdocs Price Performance

Shares of Amdocs stock opened at $80.99 on Tuesday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 52 week low of $74.32 and a 52 week high of $95.41. The stock’s 50-day simple moving average is $80.42 and its 200-day simple moving average is $82.74. The company has a market capitalization of $8.74 billion, a price-to-earnings ratio of 16.04, a PEG ratio of 1.39 and a beta of 0.40.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st were given a dividend of $0.527 per share. The ex-dividend date was Wednesday, December 31st. This represents a $2.11 annualized dividend and a dividend yield of 2.6%. Amdocs’s dividend payout ratio (DPR) is presently 41.78%.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.